Robert Sufit
Overview
Explore the profile of Robert Sufit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
874
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McDermott M, Sufit R, Domanchuk K, Volpe N, Kosmac K, Peterson C, et al.
J Vasc Surg
. 2025 Jan;
PMID: 39778757
Background: VM202 is a plasmid encoding two isoforms of hepatocyte growth factor. In preclinical studies, hepatocyte growth factor stimulated angiogenesis and muscle regeneration. This preliminary clinical trial tested the hypothesis...
2.
Willis A, Zelikovich A, Sufit R, Ajroud-Driss S, Vandenborne K, Demonbreun A, et al.
Sci Rep
. 2024 Nov;
14(1):28745.
PMID: 39567576
Weekly Steroids in Muscular Dystrophy (WSiMD) was a pilot study to evaluate once weekly prednisone in patients with Limb Girdle and Becker muscular dystrophy (LGMD and BMD, respectively). At study...
3.
McDermott M, Dayanidhi S, Leeuwenburgh C, Wohlgemuth S, Ferrucci L, Peterson C, et al.
Vasc Med
. 2024 Sep;
29(6):640-652.
PMID: 39239859
Background: Mitochondrial abnormalities exist in lower-extremity peripheral artery disease (PAD), yet the association of the ankle-brachial index (ABI) with mitochondrial respiration in gastrocnemius muscle is unknown. The association of gastrocnemius...
4.
McDermott M, Martens C, Domanchuk K, Zhang D, Peek C, Criqui M, et al.
Nat Commun
. 2024 Aug;
15(1):6890.
PMID: 39134546
No abstract available.
5.
Willis A, Zelikovich A, Sufit R, Ajroud-Driss S, Vandenborne K, Demonbreun A, et al.
medRxiv
. 2024 Jul;
PMID: 38947030
Background: Weekly Steroids in Muscular Dystrophy (WSiMD) was a pilot study to evaluate once weekly prednisone in patients with Limb Girdle and Becker muscular dystrophy (LGMD and BMD, respectively). At...
6.
McDermott M, Martens C, Domanchuk K, Zhang D, Peek C, Criqui M, et al.
Nat Commun
. 2024 Jun;
15(1):5046.
PMID: 38871717
People with lower extremity peripheral artery disease (PAD) have increased oxidative stress, impaired mitochondrial activity, and poor walking performance. NAD+ reduces oxidative stress and is an essential cofactor for mitochondrial...
7.
Ismaeel A, McDermott M, Joshi J, Sturgis J, Zhang D, Ho K, et al.
Am J Physiol Cell Physiol
. 2024 Jan;
326(2):C589-C605.
PMID: 38189132
The pathophysiology of muscle damage in peripheral artery disease (PAD) includes increased oxidant production and impaired antioxidant defenses. Epicatechin (EPI), a naturally occurring flavanol, has antioxidant properties that may mediate...
8.
Whipple M, Pfammatter A, Spring B, Rejeski W, Treat-Jacobson D, Domanchuk K, et al.
J Am Heart Assoc
. 2023 Aug;
12(17):e031182.
PMID: 37642035
Background Overweight and obesity are associated with adverse functional outcomes in people with peripheral artery disease (PAD). The effects of weight loss in people with overweight/obesity and PAD are unknown....
9.
Thangada N, Xu S, Tian L, Zhao L, Criqui M, Ferrucci L, et al.
Vasc Med
. 2023 Aug;
28(6):583-585.
PMID: 37622748
No abstract available.
10.
Ferrucci L, Candia J, Ubaida-Mohien C, Lyashkov A, Banskota N, Leeuwenburgh C, et al.
Circ Res
. 2023 May;
132(11):1428-1443.
PMID: 37154037
Background: Few effective therapies exist to improve lower extremity muscle pathology and mobility loss due to peripheral artery disease (PAD), in part because mechanisms associated with functional impairment remain unclear....